Zhenyu Pan
The Affiliated HuizhouHospital, Guangzhou Medical University · Jinshan Hospital Fudan University · Huizhou Hospital of Guangzhou Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zhenyu Pan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:50 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06809517 · Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal MetastasisGuangzhou Medical University · recruiting · Leptomeningeal Metastasis, Intrathecal Drug Delivery · principal investigator
- Ph1/Ph2NCT06809530 · Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal MetastasisGuangzhou Medical University · active not recruiting · Leptomeningeal Metastasis, Pemetrexed, PD-1 Inhibitor · principal investigator
- Ph1/Ph2NCT06762080 · Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal MetastasisGuangzhou Medical University · active not recruiting · Leptomeningeal Metastasis · principal investigator
- Ph2NCT06462079 · Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain MetastasesGuangzhou Medical University · not yet recruiting · Brain Metastasis · principal investigator
- Ph1/Ph2NCT06462092 · Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast CancerGuangzhou Medical University · recruiting · Leptomeningeal Metastases · principal investigator
- Ph2NCT06296745 · Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.Guangzhou Medical University · recruiting · Leptomeningeal Metastasis · principal investigator
- N/ANCT05305885 · Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal MetastasisThe First Hospital of Jilin University · unknown · Leptomeningeal Metastasis · principal investigator
- Ph1/Ph2NCT05289908 · Intrathecal Pemetrexed for Leptomeningeal MetastasisThe First Hospital of Jilin University · completed · Leptomeningeal Metastases · principal investigator
- Ph1/Ph2NCT03507244 · Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid TumorsThe First Hospital of Jilin University · completed · Leptomeningeal Metastasis · principal investigator
- Ph1NCT03101579 · Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung CancerThe First Hospital of Jilin University · completed · Leptomeningeal Metastases · principal investigator
- Ph2NCT03082144 · Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid TumorsThe First Hospital of Jilin University · completed · Leptomeningeal Metastasis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:50 UTC. The ranking covers the 200 most relevant of 226 PubMed records, and a shared surname and initials can bring in a namesake. All 226 on PubMed
- Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial.Clin Cancer Res · 2021506 citationsRCR 27.5
- 473 citationsRCR 29.1
- Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT.J Hepatol · 2014292 citationsRCR 9.9
- A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity.Obesity (Silver Spring) · 2016252 citationsRCR 10.2
- 238 citationsRCR 17.2
- Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.Ann Surg · 2015217 citationsRCR 7.4
- 190 citationsRCR 5.4
- Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.JAMA Psychiatry · 2019167 citationsRCR 8.4
- Randomized Controlled Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder.J Am Acad Child Adolesc Psychiatry · 2015153 citationsRCR 8.1
- Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study.Lancet Gastroenterol Hepatol · 2023136 citationsRCR 10.3